Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 09/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
STIMIT CORPORATION
INTERNAL ADDRESS
B712
*MAILING ADDRESS
20 Chapel Street
*CITY
Brookline
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02446
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Hydrogel for medical purposes; biomaterial for medical purposes; pharmaceutical preparations used to modulate an immune response;
pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immune-stimulating cells; therapeutic agents for impacting
immune-suppressive cells; pharmaceutical preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological,
urological, neoplastic, fibrotic diseases and disorders, and pain; biological preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood,
respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents in the form of injections for medical purposes for the prevention and
treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery
agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, biomaterials to extend the release of immunotherapy treatments at the
site of tumor resection; intraoperative biomaterial for delivery of immunotherapy.
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
Research and development in the field of immunotherapy; research and development in the field of oncology; pharmaceutical research and
development; providing information in the fields of oncology and immunotherapy via a website.
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Sara M. Bauer
ATTORNEY DOCKET NUMBER
2012563-0077
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Choate, Hall & Stewart LLP
STREET
Two International Place
CITY
Boston
STATE
Massachusetts
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
02110
PHONE
617-248-5000
FAX
617-248-4000
EMAIL ADDRESS
tmadmin@choate.com
OTHER APPOINTED ATTORNEY
Brenda H. Jarrell, Brian E. Reese and all other attorneys of the firm
CORRESPONDENCE INFORMATION
NAME
Sara M. Bauer
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
tmadmin@choate.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
2
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
700
*TOTAL FEES PAID
700
SIGNATURE INFORMATION
SIGNATURE
/Michael S. Goldberg/
SIGNATORY'S NAME
Michael Goldberg
SIGNATORY'S POSITION
CEO
SIGNATORY'S PHONE NUMBER
617-909-8181
DATE SIGNED
09/23/2021
SIGNATURE METHOD
Sent to third party for signature
PTO- 1478
Approved for use through 09/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97042705
Filing Date:09/23/2021
To the Commissioner for Trademarks:
MARK: SURGE (Standard Characters, see mark)
The literal element of the mark consists of SURGE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, STIMIT CORPORATION, a corporation of Delaware, having an address of
B712
20 Chapel Street
Brookline, Massachusetts 02446
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Hydrogel for medical purposes; biomaterial for medical purposes; pharmaceutical preparations used to modulate an immune response; pharmaceutical preparations for the
treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immune-stimulating cells; therapeutic agents for impacting immune-suppressive cells; pharmaceutical
preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and
disorders, and pain; biological preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological,
neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents in the form of injections for medical purposes for the prevention and treatment of oncological, viral, musculoskeletal,
immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents consisting of compounds that facilitate
delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, biomaterials to extend the release of immunotherapy treatments at the site of tumor resection; intraoperative
biomaterial for delivery of immunotherapy.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 042: Research and development in the field of immunotherapy; research and development in the field of oncology; pharmaceutical research and development; providing
information in the fields of oncology and immunotherapy via a website.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Sara M. Bauer. Other appointed attorneys are Brenda H. Jarrell, Brian E. Reese and all other attorneys of the firm. Sara M. Bauer of Choate,
Hall & Stewart LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
Two International Place
Boston, Massachusetts 02110
United States
617-248-5000(phone)
617-248-4000(fax)
tmadmin@choate.com
The docket/reference number is 2012563-0077.
Sara M. Bauer submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Sara M. Bauer
PRIMARY EMAIL FOR CORRESPONDENCE: tmadmin@choate.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: /Michael S. Goldberg/ Date: 09/23/2021
Signatory's Name: Michael Goldberg
Signatory's Position: CEO
Signatory's Phone Number: 617-909-8181
Signature method: Sent to third party for signature
Payment Sale Number: 97042705
Payment Accounting Date: 09/23/2021
Serial Number: 97042705
Internet Transmission Date: Thu Sep 23 21:11:03 ET 2021
TEAS Stamp: USPTO/BAS-XX.X.XX.XX-2021092321110318413
5-97042705-781df55af6afbc41e5dc18c35fb97
ac87a53d0ccbd194f633b99f913d2438d694e-CC
-11022655-20210923142327975439